A negative genetic interaction map in isogenic cancer cell lines reveals cancer 
cell vulnerabilities

Vizeacoumar, F. J.; Arnold, R.; Vizeacoumar, F. S.; Chandrashekhar, M.; Buzina, A.; Young, J. T.; Kwan, J. H.; Sayad, A.; Mero, P.; Lawo, S.; Tanaka, H.; Brown, K. R.; Baryshnikova, A.; Mak, A. B.; Fedyshyn, Y.; Wang, Y.; Brito, G. C.; Kasimer, D.; Makhnevych, T.; Ketela, T.; Datti, A.; Babu, M.; Emili, A.; Pelletier, L.; Wrana, J.; Wainberg, Z.; Kim, P. M.; Rottapel, R.; O'Brien, C. A.; Andrews, B.; Boone, C.; Moffat, J.

doi:10.1038/msb.2013.54

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities

MPS-Authors

/persons/resource/persons281102

Lawo, S.
CRISPR Screening, Core Facilities, Max Planck Institute for Biology of Ageing, Max Planck Society;

External Resource

https://www.ncbi.nlm.nih.gov/pubmed/24104479
(Any fulltext)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Vizeacoumar, F. J., Arnold, R., Vizeacoumar, F. S., Chandrashekhar, M., Buzina, A., Young, J. T., et al. (2013). A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities. Mol Syst Biol, 9, 696. doi:10.1038/msb.2013.54.

Cite as: https://hdl.handle.net/21.11116/0000-000B-6AB9-E

Abstract

Improved efforts are necessary to define the functional product of cancer mutations currently being revealed through large-scale sequencing efforts. Using genome-scale pooled shRNA screening technology, we mapped negative genetic interactions across a set of isogenic cancer cell lines and confirmed hundreds of these interactions in orthogonal co-culture competition assays to generate a high-confidence genetic interaction network of differentially essential or differential essentiality (DiE) genes. The network uncovered examples of conserved genetic interactions, densely connected functional modules derived from comparative genomics with model systems data, functions for uncharacterized genes in the human genome and targetable vulnerabilities. Finally, we demonstrate a general applicability of DiE gene signatures in determining genetic dependencies of other non-isogenic cancer cell lines. For example, the PTEN(-/-) DiE genes reveal a signature that can preferentially classify PTEN-dependent genotypes across a series of non-isogenic cell lines derived from the breast, pancreas and ovarian cancers. Our reference network suggests that many cancer vulnerabilities remain to be discovered through systematic derivation of a network of differentially essential genes in an isogenic cancer cell model.